AbbVie Inc. Reports Q2 2026 Earnings (Press Release)

What Happened

• AbbVie Inc. (ABBV) announced its financial results for the quarter ended June 30, 2026 via a press release dated July 31, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8‑K filed on July 31, 2026 under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: July 31, 2026 (Form 8‑K).
• Reporting period: Quarter ended June 30, 2026 (Q2 2026).
• Disclosure: Press release announcing quarterly results furnished as Exhibit 99.1 to the 8‑K (Item 2.02).
• The 8‑K itself furnishes the press release; investors should review Exhibit 99.1 for the full earnings figures, revenue, EPS, and any guidance or commentary.

Why It Matters

• Quarterly earnings announcements are primary drivers of short‑term stock moves and provide the latest revenue, earnings, and guidance information investors and analysts use to update forecasts. This 8‑K makes AbbVie’s Q2 2026 results publicly available and official; retail investors should read the attached press release for the detailed numbers and management commentary to assess the company’s recent performance.